[Non-standard discontinuation of adefovir dipivoxil causing acute exacerbation of hepatitis].
Yang
Zhan
Z
Guangzhou 8th People's Hospital, Guangzhou 510060, China.
Wu
Mao-sheng
MS
Chen
Wei-lie
WL
Xiao
Lei
L
Zhao
Ling-zhai
LZ
Wei
Shao-jing
SJ
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D016638:Critical Illness; D016207:Cytokines / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D005500:Follow-Up Studies; D006515:Hepatitis B virus / Q000187:drug effects* / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000097:blood / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D015415:Biomarkers; D016207:Cytokines; D004279:DNA, Viral; D063065:Organophosphonates; D000225:Adenine; C106812:adefovir dipivoxil